UBS Group
MPT

UBS Group’s Medical Properties Trust MPT Stock Holding History

UBS Group’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.6M Buy
2,715,531
+635,124
+31% +$3.31M ﹤0.01% 3105
2025
Q4 		$10.4M Sell
2,080,407
-1,593,699
-43% -$8.3M ﹤0.01% 3245
2025
Q3 		$18.6M Buy
3,674,106
+850,523
+30% +$3.75M ﹤0.01% 2645
2025
Q2 		$12.2M Sell
2,823,583
-3,437,492
-55% -$17M ﹤0.01% 2876
2025
Q1 		$37.8M Sell
6,261,075
-3,221,979
-34% -$16.3M 0.01% 1729
2024
Q4 		$37.5M Buy
9,483,054
+8,231,222
+658% +$36.9M 0.01% 1715
2024
Q3 		$7.32M Buy
1,251,832
+62,802
+5% +$310K ﹤0.01% 2677
2024
Q2 		$5.12M Sell
1,189,030
-493,299
-29% -$2.36M ﹤0.01% 2854
2024
Q1 		$7.91M Buy
1,682,329
+284,912
+20% +$1.09M ﹤0.01% 2487
2023
Q4 		$6.86M Buy
1,397,417
+783,653
+128% +$3.84M ﹤0.01% 2433
2023
Q3 		$3.35M Sell
613,764
-207,263
-25% -$1.66M ﹤0.01% 2954
2023
Q2 		$7.6M Buy
821,027
+109,782
+15% +$929K ﹤0.01% 2186
2023
Q1 		$5.85M Sell
711,245
-1,618,181
-69% -$17.9M ﹤0.01% 2367
2022
Q4 		$25.9M Sell
2,329,426
-1,330,477
-36% -$15.5M 0.01% 1233
2022
Q3 		$43.4M Buy
3,659,903
+3,234,770
+761% +$49M 0.02% 767
2022
Q2 		$6.49M Sell
425,133
-193,942
-31% -$3.49M ﹤0.01% 2158
2022
Q1 		$13.1M Buy
619,075
+28,703
+5% +$618K ﹤0.01% 1736
2021
Q4 		$14M Buy
590,372
+84,710
+17% +$1.81M ﹤0.01% 1847
2021
Q3 		$10.1M Sell
505,662
-8,229
-2% -$169K ﹤0.01% 2011
2021
Q2 		$10.3M Sell
513,891
-458,939
-47% -$9.82M ﹤0.01% 2003
2021
Q1 		$20.7M Buy
972,830
+11,738
+1% +$252K 0.01% 1429
2020
Q4 		$20.9M Sell
961,092
-318,556
-25% -$6.21M 0.01% 1318
2020
Q3 		$22.6M Buy
1,279,648
+507,869
+66% +$9.45M 0.01% 1100
2020
Q2 		$14.5M Sell
771,779
-461,700
-37% -$8.18M 0.01% 1268
2020
Q1 		$21.3M Sell
1,233,479
-650,539
-35% -$13.6M 0.01% 949
2019
Q4 		$39.8M Buy
1,884,018
+766,723
+69% +$15.5M 0.01% 903
2019
Q3 		$21.9M Buy
1,117,295
+390,652
+54% +$7.18M 0.01% 1170
2019
Q2 		$12.7M Sell
726,643
-34,117
-4% -$614K ﹤0.01% 1571
2019
Q1 		$14.1M Buy
760,760
+251,534
+49% +$4.48M 0.01% 1407
2018
Q4 		$8.19M Buy
509,226
+72,400
+17% +$1.15M ﹤0.01% 1729
2018
Q3 		$6.51M Sell
436,826
-123,635
-22% -$1.8M ﹤0.01% 2123
2018
Q2 		$7.87M Sell
560,461
-314,729
-36% -$4.17M ﹤0.01% 1944
2018
Q1 		$11.4M Buy
875,190
+44,833
+5% +$574K ﹤0.01% 1574
2017
Q4 		$11.4M Buy
830,357
+259,257
+45% +$3.5M ﹤0.01% 1612
2017
Q3 		$7.5M Buy
571,100
+75,955
+15% +$978K ﹤0.01% 1846
2017
Q2 		$6.37M Buy
495,145
+600
+0.1% +$7.99K ﹤0.01% 1913
2017
Q1 		$6.38M Sell
494,545
-2,977
-0.6% -$38.1K ﹤0.01% 1870
2016
Q4 		$6.12M Buy
497,522
+46,746
+10% +$605K ﹤0.01% 1916
2016
Q3 		$6.66M Sell
450,776
-30,251
-6% -$458K ﹤0.01% 1758
2016
Q2 		$7.32M Sell
481,027
-17,739
-4% -$251K ﹤0.01% 1621
2016
Q1 		$6.47M Buy
498,766
+153,299
+44% +$1.75M ﹤0.01% 1649
2015
Q4 		$3.98M Sell
345,467
-92,959
-21% -$1.06M ﹤0.01% 2163
2015
Q3 		$4.85M Buy
438,426
+152,568
+53% +$1.89M ﹤0.01% 1945
2015
Q2 		$3.75M Buy
285,858
+17,362
+6% +$242K ﹤0.01% 2369
2015
Q1 		$3.96M Sell
268,496
-160,620
-37% -$2.39M ﹤0.01% 2276
2014
Q4 		$5.91M Buy
+429,116
New +$5.75M ﹤0.01% 1961

Other funds holding MPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

UBS Group's MPT Position: Q1 2026 in Review

UBS Group increased its Medical Properties Trust (MPT) stake by 31% in Q1 2026, buying an estimated $3.31M and bringing the position to 2,715,531 shares worth $12.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3105.

UBS Group first reported a position in MPT in Q4 2014 and has held it in 46 quarters since. The position peaked at $43.4M in Q3 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • UBS Group held 2,715,531 shares of Medical Properties Trust worth $12.6M as of Q1 2026.
  • UBS Group bought 635,124 Medical Properties Trust shares in Q1 2026, an estimated $3.31M.
  • Medical Properties Trust made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3105 holding.
  • UBS Group first reported a position in Medical Properties Trust in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Medical Properties Trust position peaked at $43.4M in Q3 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.